Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORKA
626
Oruka Therapeutics
ORKA
$5.31B
| $16.4M | 0.01% |
849,410
+613,294
| +260% | +$15M |
|
627
Asure Software
ASUR
$242M
| $16.1M | 0.01% |
1,711,437
-31,450
| -2% | -$289K |
|
628
Royal Bank of Canada
RY
$287B
| $16.1M | 0.01% |
133,480
-15,100
| -10% | -$1.86M |
|
629
Air Products & Chemicals
APD
$65.5B
| $16.1M | 0.01% |
55,328
-57,183
| -51% | -$18M |
|
630
Business First Bancshares
BFST
$1.05B
| $16M | 0.01% |
623,464
+328,189
| +111% | +$8.81M |
|
|
WAY
631
Waystar Holding Corp
WAY
$4.7B
| $16M | 0.01% |
+436,190
| New | +$13.4M |
|
632
California Resources
CRC
$4.49B
| $16M | 0.01% |
308,459
+24,154
| +8% | +$1.31M |
|
633
Burford Capital
BUR
$914M
| $16M | 0.01% |
1,232,077
-54,168
| -4% | -$727K |
|
634
Insight Enterprises
NSIT
$3.85B
| $15.9M | 0.01% |
104,809
-84,609
| -45% | -$15.1M |
|
635
Deckers Outdoor
DECK
$14.1B
| $15.9M | 0.01% |
78,296
+43,918
| +128% | +$7.94M |
|
636
nCino
NCNO
$2.06B
| $15.9M | 0.01% |
473,659
+4,418
| +0.9% | +$165K |
|
637
NextEra Energy
NEE
$185B
| $15.6M | 0.01% |
217,035
-44,749
| -17% | -$3.48M |
|
638
Fair Isaac
FICO
$31.8B
| $15.6M | 0.01% |
7,821
+3,501
| +81% | +$7.48M |
|
639
Box
BOX
$4.49B
| $15.4M | 0.01% |
487,387
+271,745
| +126% | +$8.91M |
|
640
AT&T
T
$164B
| $15.3M | 0.01% |
671,830
-29,224
| -4% | -$658K |
|
641
CorVel
CRVL
$3.18B
| $15.2M | 0.01% |
136,908
+12,519
| +10% | +$1.4M |
|
642
Kymera Therapeutics
KYMR
$8.66B
| $15.2M | 0.01% |
377,384
+362,276
| +2,398% | +$16.4M |
|
643
Corcept Therapeutics
CORT
$9.98B
| $15.2M | 0.01% |
301,490
-22,527
| -7% | -$1.18M |
|
644
Globant
GLOB
$1.65B
| $15.1M | 0.01% |
70,628
+30,042
| +74% | +$6.55M |
|
645
Simulations Plus
SLP
$371M
| $15.1M | 0.01% |
542,899
+535,986
| +7,753% | +$16.3M |
|
|
BCAX
646
Bicara Therapeutics
BCAX
$1.7B
| $15M | 0.01% |
863,846
-324,345
| -27% | -$6.75M |
|
|
JMID
647
Janus Henderson Mid Cap Growth Alpha ETF
JMID
$23.5M
| $15M | 0.01% |
540,153
+340,153
| +170% | +$9.45M |
|
648
Palomar
PLMR
$3.79B
| $14.8M | 0.01% |
140,384
+95,359
| +212% | +$9.67M |
|
649
Brookfield
BN
$102B
| $14.8M | 0.01% |
386,676
-23,658
| -6% | -$891K |
|
|
CUK
650
DELISTED
Carnival PLC
CUK
| $14.8M | 0.01% |
656,770
-31,376
| -5% | -$666K |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.